3种集采与非集采注射用头孢菌素有效性和安全性的多中心研究

刘璐; 宋沧桑; 李兴德; 邓雨琴; 毛盼盼; 张函舒; 董艳珍; 程瑶瑶

doi:10.6039/j.issn.1001-0408.2024.07.10

您当前的位置：

首页 >

文章列表页 >

3种集采与非集采注射用头孢菌素有效性和安全性的多中心研究

药物与临床 | 更新时间：2025-09-25

- 3种集采与非集采注射用头孢菌素有效性和安全性的多中心研究
- Multicenter study on the efficacy and safety of 3 kinds of Cephalosporin for injection from centralized procurement or non-centralized procurement
- 中国药房 2024年35卷第7期页码：825-830
- 作者机构：
  
  1.昆明市第一人民医院药学部，昆明　650224
  2.大理大学药学院，云南大理　671003
  3.昆明医科大学附属甘美医院药学部，昆明　650224
- 作者简介：
  
  主管药师。研究方向：医院药学。E-mail：1614798517@qq.com
  主任药师，教授，硕士生导师。研究方向：临床药学、药物基因组学。E-mail：songcs163@163.com
- 基金信息：
  
  云南省卫生健康委临床药学中心建设单位项目;云南省卫生健康委医学领军人才培养计划(L-2018012);昆明市卫生科技人才培养项目——医学科技领军人才培养计划［No.2023-SW（领军）-04］
- DOI：10.6039/j.issn.1001-0408.2024.07.10
  中图分类号： R969.4
- 收稿日期：2023-09-05，
  
  修回日期：2023-11-19，
  
  录用日期：2024-01-12，
  
  纸质出版日期：2024-04-15
- 稿件说明：
移动端阅览
刘璐,宋沧桑,李兴德,等.3种集采与非集采注射用头孢菌素有效性和安全性的多中心研究[J].中国药房,2024,35(07):825-830.

LIU Lu,SONG Cangsang,LI Xingde,et al.Multicenter study on the efficacy and safety of 3 kinds of Cephalosporin for injection from centralized procurement or non-centralized procurement[J].ZHONGGUO YAOFANG,2024,35(07):825-830.
刘璐,宋沧桑,李兴德,等.3种集采与非集采注射用头孢菌素有效性和安全性的多中心研究[J].中国药房,2024,35(07):825-830. DOI： 10.6039/j.issn.1001-0408.2024.07.10.

LIU Lu,SONG Cangsang,LI Xingde,et al.Multicenter study on the efficacy and safety of 3 kinds of Cephalosporin for injection from centralized procurement or non-centralized procurement[J].ZHONGGUO YAOFANG,2024,35(07):825-830. DOI： 10.6039/j.issn.1001-0408.2024.07.10.

摘要

目的

比较国家组织药品集中采购（简称“集采”）与非集采注射用头孢唑林钠、注射用头孢呋辛钠和注射用头孢他啶治疗细菌性感染患者的有效性和安全性。

方法

回顾性收集昆明市19家医疗机构2020年1月至2022年9月使用过3种集采或非集采注射用头孢菌素治疗细菌性感染的住院患者的病例数据，采用倾向性评分匹配平衡组间基线差异后，分别比较3种集采与非集采注射用头孢菌素的有效性和安全性差异。

结果

平衡组间基线差异后，注射用头孢唑林钠集采组与非集采组各394例，注射用头孢呋辛钠集采组与非集采组各472例，注射用头孢他啶集采组504例、非集采组590例。有效性方面，注射用头孢唑林钠和注射用头孢呋辛钠集采组与非集采组的临床有效率、72 h有效率、细菌清除率及体温、白细胞计数、中性粒细胞计数、中性粒细胞百分比、C反应蛋白、降钙素原恢复率比较，差异均无统计学意义（

＞0.05）；注射用头孢他啶集采组C反应蛋白恢复至正常参考范围的患者比例显著高于非集采组（46.9% vs. 27.9%，

＜0.05），但其余有效性指标差异均无统计学意义（

＞0.05）。安全性方面，3种注射用头孢菌素集采组患者的药品不良反应发生率与非集采组比较，差异均无统计学意义（

＞0.05）；注射用头孢唑林钠集采组患者血小板计数降低的发生率显著高于非集采组（20.7% vs. 7.1%，

＜0.05），注射用头孢他啶集采组患者嗜酸性粒细胞升高的发生率显著高于非集采组（5.3% vs. 1.9%，

＜0.05）。此外，3种注射用头孢菌素其余实验室相关指标异常率的组间差异均无统计学意义（

＞0.05）。

结论

3种集采注射用头孢菌素的有效性不劣于非集采品种，安全性与非集采品种相当。

Abstract

OBJECTIVE

To compare the efficacy and safety of Cefazolin sodium for injection， Cefuroxime sodium for injection， and Ceftazidime for injection from nationally organized centralized drug procurement （hereinafter referred to as “centralized procurement”） and non-centralized procurement in patients with bacterial infection.

METHODS

The case data of hospitalized patients who had used 3 kinds of Cephalosporins for injection from centralized procurement or non-centralized procurement in the treatment of bacterial infections were retrospectively collected from 19 medical institutions in Kunming from January 2020 to September 2022. After balancing the baseline differences between the groups with the propensity score matching method， the effectiveness and safety differences of 3 kinds of Cephalosporins for injection from centralized procurement or non-centralized procurement were compared respectively.

RESULTS

After balancing the baseline differences among the groups， 394 cases in each group of Cefazolin sodium for injection from centralized procurement or non-centralized procurement， 472 cases in each group of Cefuroxime sodium for injection from centralized procurement or non-centralized procurement， 504 cases in group of Ceftazidime for injection from centralized procurement and 590 cases in group of non-centralized procurement were included in the analysis. In terms of effectiveness， there were no significant differences in clinical response rate， 72 h response rate， bacterial clearance rate， and the recovery rate of body temperature， white blood cell count， neutrophil count， neutrophil percentage， C-reactive protein， procalcitonin recovery between the centralized procurement group and non-centralized procurement group of Cefazolin sodium for injection and Cefuroxime sodium for injection （

＞0.05）. The proportion of patients in centralized procurement group of Ceftazidime for injection with C-reactive protein restored to normal reference range was significantly higher than that in non-centralized procurement group （46.9% vs. 27.9%，

＜0.05）， but there were no statistically significant differences in other effectiveness indicators among groups （

＞0.05）. In terms of safety， there was no statistical difference in the incidence of adverse drug reactions between centralized procureme

nt group and non-centralized procurement group of 3 kinds of Cephalosporins for injection （

＞0.05）； the incidence of platelet count reduction in centralized procurement group of Cefazolin sodium for injection was significantly higher than non-centralized procurement group （20.7% vs. 7.1%，

＜0.05）， the incidence of eosinophilia elevation in centralized procurement group of Ceftazidime for injection was significantly higher than non-centralized procurement group （5.3% vs. 1.9%，

＜0.05）. In addition， there was no statistically significant difference in the abnormal rates of other laboratory indicators among the three types of injection Cephalosporins （

＞0.05）.

CONCLUSIONS

The efficacy of 3 kinds of Cephalosporin for injection from centralized procurement is not inferior to non-centralized procurement varieties， and the safety is equivalent to that of non-centralized procurement varieties.

关键词

Keywords

references

马步芳，王立新，张培培，等 . 国内外质控差异可能对多组分抗生素注射剂一致性评价产生的影响 [J ] . 中国抗生素杂志， 2022 ， 47 （ 8 ）： 808 - 815 .

MA B F ， WANG L X ， ZHANG P P ， et al . Possible impact on consistency evaluation of multi-component antibiotic injections by domestic and international differences in the quality control [J ] . Chin J Antibiot ， 2022 ， 47 （ 8 ）： 808 - 815 .

杜雪，马珺，黎雯霞 . 药品带量采购存在的问题与对策分析 [J ] . 卫生经济研究， 2020 ， 37 （ 8 ）： 42 - 44 .

DU X ， MA J ， LI W X . Problems and countermeasures on existing in the development of drug volume procurement [J ] . Health Econ Res ， 2020 ， 37 （ 8 ）： 42 - 44 .

LIN X M ， KÜCK U . Cephalosporins as key lead generation beta-lactam antibiotics [J ] . Appl Microbiol Biotechnol ， 2022 ， 106 （ 24 ）： 8007 - 8020 .

JORDAN E ， VOIDE C ， PETIGNAT P A ， et al . Cephalosporins in clinical practice [J ] . Rev Med Suisse ， 2020 ， 16 （ 710 ）： 1906 - 1911 .

申玲玲，杜光，李娟，等 . 对仿制药一致性评价政策的解读 [J ] . 医药导报， 2020 ， 39 （ 5 ）： 722 - 727 .

SHEN L L ， DU G ， LI J ， et al . Interpretation on the policy of consistency evaluation of generic drugs [J ] . Her Med ， 2020 ， 39 （ 5 ）： 722 - 727 .

KWO P Y ， COHEN S M ， LIM J K . ACG clinical guideline：evaluation of abnormal liver chemistries [J ] . Am J Gastroenterol ， 2017 ， 112 （ 1 ）： 18 - 35 .

KHWAJA A . KDIGO clinical practice guidelines for acute kidney injury [J ] . Nephron Clin Pract ， 2012 ， 120 （ 4 ）： 179 - 184 .

国家食品药品监督管理总局 . 国家食品药品监督管理总局关于发布抗菌药物研发立题和临床试验2项技术指导原则的通告（2015年第9号） [EB/OL ] .（ 2015-04-03 ）[ 2023-11-21 ] . https：//www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20150403120001449.html https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20150403120001449.html .

China Food and Drug Administration . Notice of the China Food and Drug Administration on issuing two technical guiding principles for the research and development of antibacterial drugs and clinical trials （No. 9 of 2015 ）[EB/OL ] .（ 2015-04-03 ）[ 2023-11-21 ] . https：//www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20150403120001449.html https://www.nmpa.gov.cn/xxgk/ggtg/ypggtg/ypqtggtg/20150403120001449.html .

国家药品监督管理局药品审评中心 . 国家药监局药审中心关于发布《急性细菌性皮肤及皮肤结构感染抗菌药物临床试验技术指导原则》和《社区获得性细菌性肺炎抗菌药物临床试验技术指导原则》的通告（2020年第28号） [EB/OL ] .（ 2020-10-13 ）[ 2023-11-21 ] . https：//www.cde.org.cn/main/news/viewInfoCommon/2062c0715ae751fab- 54f2257fad72c8f https://www.cde.org.cn/main/news/viewInfoCommon/2062c0715ae751fab-54f2257fad72c8f .

Center for Drug Evaluation， National Medical Products Administration . Notice of the Center for Drug Evaluation， National Medical Products Administration on issuing the Technical Guidelines for Clinical Trials of Antibiotics for Acute Bacterial Skin and Skin Structural Infections and Technical Guidelines for Clinical Trials of Antibiotics for Community Acquired Bacterial Pneumonia （No. 28 of 2020 ）[EB/OL ] .（ 2020-10-13 ）[ 2022-11-21 ] . https：//www.cde.org.cn/main/news/viewInfoCommon/2062c0715ae751- fab54f2257fad72c8f https://www.cde.org.cn/main/news/viewInfoCommon/2062c0715ae751-fab54f2257fad72c8f .

U.S. Department of Health and Human Services . Common terminology criteria for adverse events （CTCAE） . version 5.0[EB/OL ] .（ 2017-11-27 ）[ 2023-11-21 ] . https：//ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf .

YANG J Y ， WEBSTER-CLARK M ， LUND J L ， et al . Propensity score methods to control for confounding in observational cohort studies：a statistical primer and application to endoscopy research [J ] . Gastrointest Endosc ， 2019 ， 90 （ 3 ）： 360 - 369 .

张凤芹，董睿涵，张惠兰 . 药物引起的血嗜酸性粒细胞增多症 [J ] . 中国实用内科杂志， 2021 ， 41 （ 12 ）： 1021 - 1025 .

ZHANG F Q ， DONG R H ， ZHANG H L . Drug-induced eosinophilia [J ] . Chin J Pract Intern Med ， 2021 ， 41 （ 12 ）： 1021 - 1025 .

KHAN D A ， BANERJI A ， BERNSTEIN J A ， et al . Cephalosporin allergy：current understanding and future challenges [J ] . J Allergy Clin Immunol Pract ， 2019 ， 7 （ 7 ）： 2105 - 2114 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

重庆地区34家医院2009－2011 年头孢菌素类药利用分析

1 例头孢菌素类抗生素致意识障碍与凝血障碍病例分析

基于药品说明书分析头孢菌素类抗菌药物皮肤过敏试验

抗菌药物致不良反应231例分析

头孢菌素类抗菌药物皮肤过敏试验现状的医疗风险分析